| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GENELUX Corp | Director | Common Stock | 68,074 | $241,662 | $3.55 | 27 Aug 2025 | Direct |
| Assertio Holdings, Inc. | Director | Common Stock | 188,251 | $210,502 | $1.12 | 14 Mar 2024 | Direct |
| GENELUX Corp | Director | Stock Option (Right to Buy) | 28,576 | 27 Aug 2025 | Direct | ||
| Assertio Holdings, Inc. | Director | Stock Option (right to buy) | 3,821 | 10 May 2023 | Direct | ||
| ChemoCentryx, Inc. | Director | Common Stock | 0 | $50.95 | 20 Oct 2022 | Direct | |
| ChemoCentryx, Inc. | Director | Restricted Stock Unit | 0 | 20 Oct 2022 | Direct | ||
| ChemoCentryx, Inc. | Director | Stock Option | 0 | 20 Oct 2022 | Direct |